__NUXT_JSONP__("/drugs/Halofuginone_Hydrobromide", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"17395-31-2",chebiId:"",chemicalFormula:"C16H17BrClN3O3.BrH",definition:"The hydrobromide salt of halofuginone, a semisynthetic quinazolinone alkaloid anticoccidial derived from the plant Dichroa febrifuga, with antifibrotic and potential antineoplastic activities. Halofuginone specifically inhibits collagen type I gene expression and matrix metalloproteinase 2 (MMP-2) gene expression, which may result in the suppression of angiogenesis, tumor stromal cell development, and tumor cell growth. These effects appear to be due to halofuginone-mediated inhibition of the collagen type I and MMP-2 promoters. Collagen type I and MMP-2 play important roles in fibro-proliferative diseases.",fdaUniiCode:"PTC2969MV1",identifier:"C2656",preferredName:b,semanticType:"Organic Chemical",subclassOf:["C1971"],synonyms:["HALOFUGINONE HYDROBROMIDE",b,"Halofuginone IV (intravenous)","Halofuginone hydrobromide","RU 19110","Tempostatin","halofuginone hydrobromide"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FHalofuginone_Hydrobromide",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Halofuginone_Hydrobromide","Halofuginone Hydrobromide","2021-10-30T13:38:03.563Z")));